Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Deffered Revenue (2016)

Lisata Therapeutics' Non-Current Deffered Revenue history spans 4 years, with the latest figure at $4.6 million for Q4 2016.

  • For Q4 2016, Non-Current Deffered Revenue changed N/A year-over-year to $4.6 million; the TTM value through Dec 2016 reached $4.6 million, changed N/A, while the annual FY2016 figure was $4.6 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue reached $4.6 million in Q4 2016 per LSTA's latest filing, up from $143734.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $4.6 million in Q4 2016 to a low of $143734.0 in Q3 2012.